Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
3
×
national blog main
boston
boston blog main
boston top stories
clinical trials
national top stories
san diego blog main
san diego top stories
acute myeloid leukemia
adverum biotechnologies
ally bridge group
ambit biosciences
athena countouriotis
big data analytics
biotech ipos
blackrock
brett zbar
bristol-myers squibb
casdin capital
cormorant asset management
daiichi sankyo
diabetic nephropathy
dyne therapeutics
eventide asset management
fda
focal segmental glomerulosclerosis
goldfinch bio
halozyme therapeutics
hbm healthcare investments
hbm partners
irving investors
jay ghosh
jean cui
lilly asia ventures
metacrine
myotonic dystrophy type 1
nextech invest
nonalcoholic steatohepatitis
What
drug
3
×
million
raised
3
×
biotech
company
genetic
ipo
medicines
new
therapeutics
analysis
athena
bio
bring
brings
cancer
ceo
chief
countouriotis
develop
developing
diseases
disorders
dyne
dyne’s
employing
financing
gets
goldfinch
kidney
later
lead
medical
mezzanine
muscle
muscular
names
officer
old
preclinical
Language
unset
Current search:
drug
×
biotech
×
raised
×
" life sciences "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
